Klinikum der Universität München (LMU Klinikum)

Therapy landscape in patients with metastatic HER2-positive breast cancer: Data from the PRAEGNANT real-world breast cancer registry (2019) Lux MP, Nabieva N, Hartkopf AD, Huober J, Volz B, Taran FA, Overkamp F, et al. Journal article Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial (2019) Janning M, Müller V, Vettorazzi E, Cubas-Cordova M, Gensch V, Ben-Batalla I, zu Eulenburg C, et al. Journal article Prevention of Cervical Cancer (2019) Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T, Haedicke J, et al. Journal article, Review article Quality assurance guidelines for interstitial hyperthermia (2019) Trefna HD, Schmidt M, Van Rhoon GC, Kok HP, Gordeyev SS, Lamprecht U, Marder D, et al. Journal article High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma (2019) Polifka I, Agaimy A, Herrmann E, Spath V, Trojan L, Stoeckle M, Becker F, et al. Journal article Targeted Therapy of Melanoma (2018) Berking C Journal article Dose-compatible grating-based phase-contrast mammography on mastectomy specimens using a compact synchrotron source (2018) Eggi E, Grandl S, Sztrokay-Gaul A, Dierolf M, Jud C, Heck L, Burger K, et al. Journal article Triple therapy for metastatic melanoma Triple-Therapie bei metastasiertem Melanom (2018) Zacher M, Heppt M, Berking C Journal article Sarcoidosis triggered by immune checkpoint blockade Sarkoidose getriggert durch Immuncheckpoint-Blockade (2018) Heppt M, Niesert AC, Flaig M, Berking C Journal article Aggressive malignant melanoma in a patient with urticaria pigmentosa Foudroyant verlaufendes malignes Melanom bei Urticaria pigmentosa (2018) Ruini C, Hartmann D, Flaig MJ, Von Braunmuehl T, Berking C Journal article